Travoprost: uses, dosing, side effects & brands
Travoprost is a prostaglandin analog sold in the U.S. under 4 brand and generic names, for open-angle glaucoma. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.
Key facts
- Drug class
- Prostaglandin Analog
- Treats (across its forms)
- Open-Angle Glaucoma
- Available as
- Drops · Implant
- Sold as
- 4 products — Izba, Travatan Z and Idose Tr, and others
- Prescription?
- Prescription only
- Generic available?
- Not in our catalog
- What the pharmacy pays
- about $10 per ml — not your price
How Travatan Z is dosed
From the FDA label for Travatan Z (application NDA021994). Other travoprost products — different forms, different strengths — are dosed differently. Follow the label for the one you were prescribed.
The recommended dosage is one drop in the affected eye(s) once daily in the evening. TRAVATAN Z should not be administered more than once daily since it has been shown that more frequent administration of prostaglandin analogs may decrease the IOP-lowering effect. Reduction of the IOP starts approximately 2 hours after the first administration with maximum effect reached after 12 hours. TRAVATAN Z may be used concomitantly with other topical ophthalmic drug products to lower IOP. If more than one topical ophthalmic drug is being used, the drugs should be administered at least 5 minutes apart. One drop in the affected eye(s) once daily in the evening (2)
Everything below is the FDA label for Travatan Z (drops). Travoprost is also sold as implant, and those are different medicines to take — follow the label for the one you were prescribed.
Travatan Z side effects
Most common adverse reaction (30% to 50%) is conjunctival hyperemia (6.1) To report SUSPECTED ADVERSE REACTIONS, contact Novartis Pharmaceuticals Corporation at 1-888-669-6682 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The most common adverse reaction observed in controlled clinical trials with TRAVATAN and TRAVATAN Z was ocular hyperemia, which was reported in 30% to 50% of patients. Up to 3% of patients discontinued therapy due to conjunctival hyperemia. Ocular adverse reactions, reported at an incidence of 5% to 10% in these clinical trials, included decreased visual acuity, eye discomfort, foreign body sensation, pain, and pruritus. Ocular adverse reactions, reported at an incidence of 1% to 4% in clinical trials with TRAVATAN or TRAVATAN Z, included abnormal vision, blepharitis, blurred vision, cataract, conjunctivitis, corneal staining, dry eye, iris discoloration, keratitis, lid margin crusting, ocular inflammation, photophobia, subconjunctival hemorrhage, and tearing. Non-ocular adverse reactions, reported at an incidence of 1% to 5% in these clinical studies, were…
Who shouldn’t take Travatan Z
None. None (4)
Every travoprost product we track (4)
Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Drops | Generic | $10 | View → | |
| 2 | 68/100 | Prescription | Drops | Generic | $10 | View → | |
| 3 | Not yet rated | Prescription | Implant | Generic | $10 | View → | |
| 4 | Not yet rated | Prescription | Drops | Generic | $10 | View → |
How long travoprost keeps
No travoprost label we read sets a separate limit for after opening, but they do specify how it must be stored — and the stability behind any date assumes those conditions.
Does travoprost expire? The in-use limits and storage rules from its labelsTravoprost and breastfeeding
From LactMed, the US National Library of Medicine’s Drugs and Lactation Database — quoted, not rewritten.
Full LactMed record for travoprost: levels in milk, effects in breastfed infants, and the drugs it would consider insteadNo information is available on the use of travoprost during breastfeeding. Because of its short half-life it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. Professional guidelines consider prostaglandin eye drops acceptable during breastfeeding. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
National Institute of Child Health and Human Development, record revised February 15, 2025. LactMed states its information is not a substitute for professional judgement.
What people report to the FDA about travoprost
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 3,848 reports naming travoprost, and the FDA flagged 55% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- treatment failure892 reports
- fatigue147 reports
- eye irritation136 reports
- dyspnoea128 reports
- dizziness125 reports
- diarrhoea120 reports
- intraocular pressure increased117 reports
- headache113 reports
Read these as a signal, not a rate. A report does not mean travoprost caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.
Source: openFDA drug/event (FAERS), retrieved July 26, 2026.
Related calculators
Frequently asked questions
What is Travatan Z?
Travatan Z (Travoprost) is a prostaglandin analog used to treat Open-Angle Glaucoma.
What kind of drug is travoprost?
The FDA classifies travoprost as a prostaglandin analog. Prostaglandin analogs (used as eye drops for glaucoma) activate FP receptors that relax the eye's drainage tissues, helping fluid flow out more easily. This lowers the pressure inside the eye and protects the optic nerve. If you are checking whether it is safe to combine with something else, the class is what matters — two drugs from the same class usually should not be stacked.
Can you take travoprost with other medicines?
It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run travoprost against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.
What brand names is travoprost sold under?
We track 4 travoprost-containing products in the U.S.: Izba, Travatan Z, Idose Tr and Travatan. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.
What forms does travoprost come in?
Across the brands we track, travoprost is currently marketed as drops and implant, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.
Is there a generic travoprost?
We do not currently list a generic-labelled travoprost product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.
Cite this page
- APA
- pharmaranks. (2026, July 24). Travoprost: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/travoprost
- MLA
- “Travoprost: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/travoprost.
We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.
Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.
Read the full FDA label for travoprost on DailyMed (NIH) ↗.